We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of White Noise In High Noise Environment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02647138
Recruitment Status : Completed
First Posted : January 6, 2016
Last Update Posted : June 17, 2019
Sponsor:
Collaborator:
MARPAC
Information provided by (Responsible Party):
Weill Medical College of Cornell University

Brief Summary:
Many patients complain to clinicians that they have difficulty sleeping appears to be due to environmental noise. There is a common perception that acute noises are more troublesome than continuous noises in the effect on individual sleep quality. Therefore the goal is to use a Marpac white noise maker with a continuous noise to see its effect on individuals that have difficulty sleeping in a high noise environment.

Condition or disease Intervention/treatment Phase
Insomnia Other: white noise Not Applicable

Detailed Description:

Insomnia patients will be recruited based on their perception of high noise in their apartment. The investigators will screen patients during the first meeting using The Mini International Neuropsychiatric Interview 6.0 (MINI 6.0). At baseline, an Insomnia Severity Index will be administered.

The study will consist of a one week baseline period in which noise levels will be monitored using spectral analysis and decibel levels and sleep duration will be recorded using a subjective sleep log and wrist actigraphy for objective measurement. At the end of the first week an Insomnia Severity Index will be administered.

During the second week, a treatment period with a white noise machine using a fixed decibel level will be installed in the bedrooms of the subjects. The room noise will continue to be monitored via spectral analysis as well as decibel levels while the patients are wearing actigraphs and keeping a sleep log. At the end of the second week an Insomnia Severity Index will be administered.

During the third week, the white noise machine will be removed and the rooms will still be monitored for sound via spectral analysis and decibel levels and the subject will wear an actigraph and keep a sleep log. At the end of the third week an Insomnia Severity Index will be administered.

The investigators will use Analysis of Covariance (ANCOVA) with baseline vs. white noise to analyze differences. The investigators will use an Acute Noise Index, in which noise spikes of 2 standard deviations from the mean of the entire nights decibel levels count as a noise event.

Noise levels in subjects bedroom will be collected throughout the study along with subjects sleep activity using an actigraph and sleep log.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 10 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Effect of White Noise In High Noise Environment
Study Start Date : December 2015
Actual Primary Completion Date : December 2018
Actual Study Completion Date : December 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Noise

Arm Intervention/treatment
Experimental: White Noise
Subject will have white noise machine placed in room.
Other: white noise
exposure to white noise




Primary Outcome Measures :
  1. Sleep Latency data using the actigraph [ Time Frame: Three weeks ]
    Subjects will have three weeks of sleep latency data using the actigraph and this data will be analyzed and presented.


Secondary Outcome Measures :
  1. Sleep Latency data using sleep diaries [ Time Frame: Three Weeks ]
    Subjects will have three weeks of sleep latency data using sleep diaries and this data will be analyzed and presented.

  2. Insomnia Severity Index [ Time Frame: Three Weeks ]
    Subjects will complete an Insomnia Severity Index at the end of each of the three weeks of the study.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Inclusion criteria for each participant are as follows: Must be between 18 and 100 years old
  • No significant psychiatric conditions based on the The Mini International Neuropsychiatric Interview 6.0 (MINI 6.0)
  • Not currently using narcotics, psychotropic or hypnotic medications and willing to refrain from using these medications during the course of the study
  • Limits caffeine consumption to less than or equal to 2 coffee servings, or equivalent per day before 12 noon
  • Limits alcohol intake to 7-drinks per week and less than or equal to 1 drinks on any one night
  • Must adjust alcohol consumption to 7-drinks per week and less than or equal to 1 drink on any one night for at least two weeks before study begins, and must not consume alcohol later than 8pm
  • Naps less than or equal to 1-hour per week according to subjective report
  • For at least 3 times a week a minimum of 30 minute sleep latency or 30 minutes of total nighttime awakening due to subjective elevated noise.

Exclusion Criteria:

  • Exclusion criteria for each participant are as follows: Younger than 18 years old or older than 100 years old
  • Significant psychiatric conditions based on the The Mini International Neuropsychiatric Interview 6.0 (MINI 6.0)
  • Currently using narcotics, psychotropic or hypnotic medications and not willing to refrain from using these medications during the course of the study
  • Does not limit caffeine consumption to less than or equal to 2 coffee servings, or equivalent per day
  • Does not limit alcohol intake to 7-drinks per week and less than or equal to 1 drinks on any one night , consumes alcohol later than 8pm
  • Naps more than 1-hour per week according to subjective report
  • Not at least 3 times a week at least 30 minute sleep latency or not 30 minutes of total nighttime awakening due to subjective elevated noise

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02647138


Locations
Layout table for location information
United States, New York
Weill Cornell Medical College Center for Sleep
New York, New York, United States, 10065
Sponsors and Collaborators
Weill Medical College of Cornell University
MARPAC
Investigators
Layout table for investigator information
Principal Investigator: Ana C Krieger, MD, MPH Weill Medical College of Cornell University
Layout table for additonal information
Responsible Party: Weill Medical College of Cornell University
ClinicalTrials.gov Identifier: NCT02647138    
Other Study ID Numbers: 1502015935
First Posted: January 6, 2016    Key Record Dates
Last Update Posted: June 17, 2019
Last Verified: June 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: There is no plan to make IPD available.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No